invobioscience.com (INVO) Price to Earnings Ratio

Corporate emblem and logo of INVO Bioscience (INVO)

Organic growth of the clinic network and the implementation of cultivation systems are yielding results, and the debt load is already priced in, as confirmed by this price chart where the indicator stands at -0.20. INVO Bioscience, Inc. (INVO) relies on the production of sophisticated reproductive health devices, ensuring stable profits through the diversification of component supplies. The creation of affordable embryo incubators provides access to the mass market.

INVO Bio (INVO) Price to Earnings Ratio: for the period 07/04/2022 - 04/28/2025

Comprehensive metric breakdowns and analytics for INVO Bioscience Inc. (INVO)

- price and consensus price forecast:
Stock Price INVO Bio|INVO - Price Target Chart
- market capitalization details:
Market Value INVO Bioscience, Inc.|INVO - Enterprise Value
- book capitalization information:
Net Assets per Share INVO Bioscience|INVO - Company Net Assets|Market Capitalization to Net Assets invobioscience.com|INVO - Company Total Assets
- debt and solvency information:
Debt to Capital INVO Bioscience, Inc.|INVO - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio INVO Bio|INVO - Company Total Debt|Debt to Net Assets Ratio INVO Bioscience, Inc.|INVO - Company Long-Term Debt|Company Current Liabilities INVO Bioscience|Immediate Liquidity invobioscience.com
- earnings and market multiples details:
INVO - Net Profit|Net Profit Forecast INVO Bioscience, Inc.|INVO - P/E Multiple|Market Cap to Projected Earnings INVO Bio|INVO - PEG Multiple|Enterprise Value to EBITDA Ratio INVO Bioscience, Inc.|INVO - Operating profit EBITDA|Net earnings per share (EPS TTM) INVO Bioscience|INVO - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months invobioscience.com|INVO - Net earnings per share growth this year|Expected earnings per share trend next year INVO Bioscience, Inc.
General company analysis:invobioscience.com - INVO
Original product of invobioscience.com

FDA patents for IVF capsules create a significant defensive moat for INVO Bioscience, Inc. (INVO) against competitors. Analyzing the company's P/E valuation, an investor sees a current ratio of -0.20. This multiple relates the stock's market value to net income, measuring the market's confidence in future earnings. Low values may signal stagnation, while inflated figures suggest a risk of correction. High switching costs confirm the fundamental resilience of the business.

Analysis of competing companies

P/E Multiple bostonscientific.com|Price to Earnings Ratio Edwards Lifesciences Corporation (EW)|Price to Earnings Ratio RMD (ResMed Inc)|P/E Multiple PODD (OmniPod)|Business Payback Period Zimmer Biomet (ZBH)|COO: Price to Earnings Ratio|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E Multiple|Price to Earnings Multiple AORT (Artivion Corp)|Price to Earnings Ratio ENOV (Enovis Corporation)|IART (integralife.com) - Company Value to Net Income|Price to Earnings Ratio Establishment Labs Holdings Inc. ESTA|BBNX - Price to Earnings Ratio|Iradimed - P/E Multiple|Market Cap to Earnings Embecta Health|TNDM: P/E Multiple|Price to Earnings Multiple AXGN|SIBN (SI-BONE) - P/E Multiple|Orthofix Medical (OFIX) - Business Payback Period|P/E Multiple BVS|Price to Earnings Ratio orthopediatrics.com KIDS|P/E Multiple TMCI (Treace Medical Concepts)|P/E Multiple blade.com SRTA|CARL - Price to Earnings Ratio|RXST: Price to Earnings Ratio|CLPT (clearpointneuro.com) - Price to Earnings Ratio|Stereotaxis Corporation - Company Value to Net Income|STIM (Neuronetics, Inc.) - P/E Multiple|Market Cap to Earnings sightsciences.com SGHT|Price to Earnings Ratio Orchestra BioMed, Inc. (OBIO)|anikatherapeutics.com (ANIK) - Market Cap to Net Income Ratio|InspireMD Corp - Price to Earnings Ratio|P/E Multiple Jin Medical International Ltd. ZJYL|Vivani - P/E Multiple|Business Payback Period Xtant Medical Holdings XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Price to Earnings Ratio|Market Cap to Net Income MODD (Modular Medical, Inc.)|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio Envoy Medical Inc (COCH)|P/E Multiple VVOS|NVNO - Market Cap to Earnings|Price to Earnings Ratio Sintx Technologies, Inc. SINT|TNON: Price to Earnings Multiple|LFWD: Price to Earnings Ratio|Autonomix Medical, Inc. - Market Price to Net Income Ratio|IVF: P/E Multiple|BBLG - Business Payback Period|Price to Earnings Ratio Axonics|Price to Earnings Multiple BIOL (BIOLASE Inc.)|Price to Earnings Ratio DYNT (Dynatronics Corporation)|Price to Earnings Ratio FNA (paragon28.com)